Forschungsprojekte
Ergebnisse pro Seite:
10
2017 - 2018
Evaluation of the anti-fibrotic effect of anti-fibrotic compounds in experimental biliary liver fibrosis- Univ.-Prof. Dr. Dr. Detlef Schuppan
2017 - 2020
Modulation of allergen-induced lung and gut inflammation by nutritional wheat amylase trypsin inhibitors (ATIs), activators of the innate immune system- Univ.-Prof. Dr. Dr. Detlef Schuppan,
- PD Dr. Iris Bellinghausen
2017 - 2021
CRC 1066/2: Nanodimensional polymer therapeutics for tumor therapy. "Therapy of metastatic melanoma by addressing tolerance inducing M2-macrophages with therapeutic nanoparticles"- Univ.-Prof. Dr. Dr. Detlef Schuppan,
- PD Dr. Andrea Tüttenberg
2017 - 2021
SFB 1066/2: “Therapy of Metastatic Melanoma by Addressing Tolerance Inducing M2-Macrophages with therapeutic Nanoparticles”.- Prof. Dr. Dr. Detlef Schuppan
2017 - 2020
DFG Allergen: „Modulation of allergen-induced lung and gut inflammation by nutritional wheat amylase trypsin inhibitors (ATIs), activators of the innate immune system”.- Prof. Dr. Dr. Detlef Schuppan
2017 - 2022
“Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS)”.- Univ.-Prof. Dr. Dr. Detlef Schuppan,
- PD Dr. Jörn Schattenberg
2017 - 2020
SPP 1656: “Functional consequences of intestinal microbiota altered by ingestion of gluten and wheat alpha-amylase-trypsin inhibitors”.- Prof. Dr. Dr. Detlef Schuppan
2016
Impact of dietary factors on the gut-CNS-axis - implication for CNS autoimmunity- Univ.-Prof. Dr. Dr. Detlef Schuppan